4.37
Olema Pharmaceuticals Inc Borsa (OLMA) Ultime notizie
Olema Pharmaceuticals (NASDAQ:OLMA) Receives Buy Rating from HC Wainwright - MarketBeat
Olema Pharmaceuticals stock hits 52-week low at $4.05 - Investing.com
Promising Efficacy of Olema Pharmaceuticals’ Palazestrant Supports Buy Rating - TipRanks
Olema Pharmaceuticals stock hits 52-week low at $4.05 By Investing.com - Investing.com UK
Olema Pharmaceuticals (NASDAQ:OLMA) Given Buy Rating at HC Wainwright - MarketBeat
Olema Pharmaceuticals (NASDAQ:OLMA) Earns “Buy” Rating from HC Wainwright - Defense World
Olema Pharmaceuticals: Promising Clinical Results and Strong Financial Health Support Buy Rating - TipRanks
Olema Pharmaceuticals (OLMA) Expected to Announce Earnings on Monday - MarketBeat
Olema updated palazestrant combination trial, says Oppenheimer - MSN
Olema Pharmaceuticals stock holds $30 target at H.C. Wainwright By Investing.com - Investing.com UK
Y Intercept Hong Kong Ltd Buys Shares of 19,001 Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
Promising Efficacy of Olema Pharmaceuticals’ Breast Cancer Treatment Drives Buy Rating - TipRanks
Olema Pharmaceuticals Unveils Strategic Priorities and Pipeline - TipRanks
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Olema's New Chief Legal Officer Receives 450,000 Stock Options as Part of Inducement Grants - StockTitan
Promising Developments in Olema Pharmaceuticals’ Breast Cancer Treatment Drive Buy Rating - TipRanks
AstraZeneca data ‘positive’ for Olema’s palazestrant, says H.C. Wainwright - TipRanks
Olema Pharmaceuticals stock hits 52-week low at $4.59 By Investing.com - Investing.com South Africa
Olema Pharmaceuticals stock hits 52-week low at $4.59 - Investing.com India
When the Price of (OLMA) Talks, People Listen - Stock Traders Daily
Vontobel Holding Ltd. Acquires Shares of 10,647 Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
Olema Oncology to Present at the TD Cowen 45th Annual Health Care Conference - GlobeNewswire
Can Olema's Breast Cancer Breakthrough Transform Patient Care? CEO Reveals Latest Data - StockTitan
Mehta named CMO, Greenberg CBO at Nura Bio - BioCentury
Olema Oncology Appoints Shawnte M. Mitchell, J.D. as Chief Legal Officer and Corporate Secretary - GlobeNewswire
Key Executive Hire: Biotech Veteran with 20-Year Track Record Joins Olema's C-Suite - StockTitan
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Short Interest Down 22.6% in January - MarketBeat
Olema Pharmaceuticals (NASDAQ:OLMA) Stock Price Down 5.4%Should You Sell? - MarketBeat
Olema Pharmaceuticals: Interesting But Undifferentiated Data (NASDAQ:OLMA) - Seeking Alpha
Olema Pharmaceuticals Inc (NASDAQ: OLMA) Slashes -5.36%: What Could Be On The Way Going Forward? - Stocks Register
SG Americas Securities LLC Has $102,000 Stock Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
OLMA’s Market Quandary: Decoding the Ups and Downs of 2023 - The InvestChronicle
Upward Trajectory: Olema Pharmaceuticals Inc (OLMA) Posts a Slidee, Closing at 5.69 - The Dwinnex
The Significance of Moving Averages in Olema Pharmaceuticals Inc Inc. (OLMA) Price Performance - The InvestChronicle
There is no way Olema Pharmaceuticals Inc (OLMA) can keep these numbers up - SETE News
OLMAOlema Pharmaceuticals, Inc. Latest Stock News & Market Updates - StockTitan
Olema Pharma's Strategic Talent Acquisition: $1.7M in Equity Grants Signals Growth Push - StockTitan
Olema Pharmaceuticals Inc (OLMA) Becoming More Attractive for Investors - Knox Daily
Are Olema Pharmaceuticals Inc (OLMA) shares a good deal now? - US Post News
Financial Metrics Exploration: Understanding Olema Pharmaceuticals Inc (OLMA) Through Ratios - The Dwinnex
Olema Oncology to Participate in Upcoming Investor Conferences - The Manila Times
Exclusive Access: Olema Pharmaceuticals Reveals Latest Oncology Progress at Two Elite Healthcare Forums - StockTitan
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):